Rezolute (RZLT) Cash from Financing Activities (2010 - 2026)
Rezolute (RZLT) reported Cash from Financing Activities of $747000.0 for Q1 2026, up 7370.0% on a YoY basis from $10000.0 in Q1 2025, and up 109.83% sequentially from $356000.0 in Q4 2025.
Rezolute (RZLT) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Cash from Financing Activities data on file, last reported at $747000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 7370.0% year-over-year to $747000.0; the trailing twelve-month figure through Mar 2026 stood at $103.2 million (up 48.47% YoY), and the FY2025 full-year result was $107.3 million, up 70.28% from the prior year.
- Cash from Financing Activities climbed to $747000.0 in Q1 2026, from $356000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $101.2 million in Q2 2025 to a low of -$19000.0 in Q1 2022.
- A 4-year average of $23.2 million and a median of $829000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities tumbled 83.44% in 2025 and surged 7370.0% in 2026, its largest moves.
- Tracing RZLT's Cash from Financing Activities over 4 years: stood at $11.6 million in 2022, then sank by 94.32% to $657000.0 in 2024, then tumbled by 45.81% to $356000.0 in 2025, then soared by 109.83% to $747000.0 in 2026.
- Business Quant data shows RZLT's Cash from Financing Activities at $747000.0 in Q1 2026, $356000.0 in Q4 2025, and $911000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 53,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 68.63 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 238.74 Mn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | 747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 747,000.00 |
| Mar 31, 2026 | 747,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | 101.16 Mn |
| Jun 30, 2025 | 101.16 Mn |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Dec 31, 2024 | 657,000.00 |
| Sep 30, 2024 | 5.50 Mn |
| Sep 30, 2024 | 5.50 Mn |
| Jun 30, 2024 | 63.33 Mn |
| Jun 30, 2024 | 63.33 Mn |
| Mar 31, 2024 | -3,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Sep 30, 2022 | 11.57 Mn |
| Sep 30, 2022 | 11.57 Mn |